Blood Transfusion Nursing: Administration, Monitoring, and Transfusion Reaction Management

The single most dangerous moment in blood transfusion is the final verification at the bedside — the point where the right unit of blood is matched to the right patient. ABO incompatibility from misidentification is the leading cause of fatal transfusion reactions, and it is entirely preventable through rigorous verification. This is why blood banks and hospitals mandate a two-nurse (or nurse-plus-one-licensed-provider) verification at the bedside immediately before administration. The verification process requires matching FIVE elements between the patient, the blood product label, and the blood bank compatibility tag: (1) patient name, (2) medical record number, (3) blood type of the patient, (4) blood type of the product, (5) unit number on the blood bag matching the unit number on the compatibility tag. Both verifiers must independently confirm all five elements — one nurse reads while the other verifies, then they switch roles. Any discrepancy, no matter how small, stops the transfusion until resolved with the blood bank. Additional pre-transfusion requirements: informed consent must be documented. Baseline vital signs (temperature, heart rate, blood pressure, respiratory rate, SpO2) must be recorded within 30 minutes before starting the transfusion. A patent IV line of appropriate gauge (18-20 gauge for most blood products; smaller gauges slow the infusion and can cause hemolysis of red cells) with normal saline (0.9% NaCl) running must be established. No other IV solutions or medications should be infused through the same line as blood — lactated Ringer's contains calcium which can cause clotting, and dextrose solutions can cause hemolysis. The blood product must be started within 30 minutes of leaving the blood bank (no pre-storage at the nursing station) and completed within 4 hours of leaving the blood bank (bacterial contamination risk increases with time at room temperature). If the transfusion will not be completed within 4 hours, the blood bank should issue smaller aliquots.

The first 15 minutes of a blood transfusion are the highest-risk period. Most acute hemolytic reactions — the most dangerous type — manifest within the first 50 mL of infusion. For this reason, the standard protocol is to run the first 15 minutes slowly (typically 2 mL/min or about 25-50 mL total) while remaining at the bedside. Vital signs are taken at baseline, at 15 minutes, and then per facility policy (commonly every 30-60 minutes during the transfusion and once after completion). After the first 15 minutes, if the patient shows no signs of reaction, the rate can be increased to the prescribed infusion rate. Typical rates: PRBCs (packed red blood cells) run over 1.5-4 hours per unit depending on the clinical situation and the patient's fluid tolerance. Patients with heart failure or volume-sensitive conditions require slower rates — sometimes 4 hours per unit with furosemide ordered between units. Platelets infuse faster, typically over 15-30 minutes per unit. FFP (fresh frozen plasma) is infused over 30-60 minutes per unit. During the transfusion, monitor for: fever (temperature rise of 1°C/1.8°F or more above baseline), chills, rigors, flushing, urticaria (hives), itching, back or flank pain, chest pain, dyspnea, hypotension, tachycardia, dark urine, and anxiety or a feeling of 'impending doom' (which is a genuine and classic symptom of acute hemolytic reactions, not a subjective complaint to dismiss). Any of these signs requires stopping the transfusion and initiating the reaction protocol. Documentation includes: the verification process, baseline vitals, the time the transfusion started, the rate, all vital sign sets during and after the transfusion, the patient's tolerance, the volume infused, and any adverse reactions. Each unit gets its own documentation. This documentation is both a patient safety tool and a legal record.

Acute hemolytic transfusion reaction (AHTR) is the most dangerous and is caused by ABO incompatibility — the patient's antibodies attack the transfused red blood cells, triggering massive intravascular hemolysis, DIC (disseminated intravascular coagulation), renal failure, and potentially death. Signs appear within minutes: fever, chills, low back pain (from renal involvement), hemoglobinuria (red/brown urine), hypotension, tachycardia, chest tightness, and a sense of impending doom. Nursing actions: STOP the transfusion immediately. Keep the IV line open with normal saline. Do NOT disconnect the blood tubing — the blood bank needs it for investigation. Notify the provider and the blood bank. Obtain a post-reaction blood specimen and urine specimen. Monitor vitals every 15 minutes. Anticipate orders for IV fluids (to support renal perfusion), vasopressors if hypotensive, and labs (direct Coombs test, haptoglobin, LDH, bilirubin, coagulation studies). Febrile non-hemolytic transfusion reaction (FNHTR) is the most common reaction type. It presents as a temperature rise of ≥1°C during or within 4 hours of transfusion, often with chills and rigors but without hemolysis. It is caused by cytokines released from donor white blood cells or recipient antibodies against donor WBC antigens. Nursing actions: stop the transfusion, notify the provider, administer antipyretics (acetaminophen) as ordered. The key nursing judgment is distinguishing a benign febrile reaction from the early signs of a hemolytic reaction — both start with fever. The differentiating features are that FNHTR does not cause back pain, hemoglobinuria, or hypotension. When in doubt, treat it as a potential hemolytic reaction until proven otherwise. Allergic reactions range from mild (urticaria, itching) to anaphylaxis. Mild allergic reactions (hives, pruritus without systemic symptoms) can often be managed by pausing the transfusion, administering diphenhydramine (Benadryl) as ordered, and resuming at a slower rate once symptoms resolve — this is one of the few situations where a transfusion may be resumed after a reaction. Anaphylaxis (hypotension, bronchospasm, angioedema, stridor) requires stopping the transfusion permanently, epinephrine administration, airway management, and emergency response. Transfusion-associated circulatory overload (TACO) occurs when the volume of transfused blood exceeds the patient's cardiac capacity, causing pulmonary edema. Signs: dyspnea, orthopnea, jugular venous distension, crackles on lung auscultation, elevated blood pressure. Risk factors: heart failure, renal failure, elderly patients, rapid infusion rate. Management: stop or slow the transfusion, elevate the head of bed, administer diuretics as ordered, provide supplemental oxygen. Prevention is key: infuse slowly (4 hours per unit) in at-risk patients and consider furosemide between units.

Understanding what each blood product contains and why it is ordered helps nurses anticipate problems and educate patients. Packed Red Blood Cells (PRBCs) contain concentrated red blood cells with most of the plasma removed. They are ordered to increase oxygen-carrying capacity in anemia, acute blood loss, or symptomatic low hemoglobin. One unit of PRBCs raises hemoglobin by approximately 1 g/dL and hematocrit by approximately 3% in an average adult. They must be ABO and Rh compatible. Platelets are ordered for thrombocytopenia (low platelet count) or platelet dysfunction to prevent or treat bleeding. One unit of apheresis platelets (single donor) raises the platelet count by approximately 30,000-60,000/µL. Platelets must be ABO compatible (preferred but not absolute) and should be Rh compatible when possible, especially for Rh-negative women of childbearing age. Platelets are stored at room temperature on a continuous agitator — they are NOT refrigerated (cold causes platelet activation and clumping). This room-temperature storage also makes platelets the highest bacterial contamination risk of all blood products. Fresh Frozen Plasma (FFP) contains all clotting factors and is ordered for coagulopathy (elevated INR/PT), massive transfusion, or specific clotting factor deficiencies. FFP must be ABO compatible. It is stored frozen and must be thawed before administration (usually takes 20-30 minutes in the blood bank). Once thawed, it must be transfused within 24 hours. Cryoprecipitate is a concentrated source of fibrinogen, Factor VIII, Factor XIII, von Willebrand factor, and fibronectin. It is primarily ordered for hypofibrinogenemia (fibrinogen < 100 mg/dL), often in the context of DIC or massive hemorrhage. Cryo does not require ABO matching. NurseIQ generates practice questions covering blood product selection, compatibility, and administration protocols — the exact content tested on NCLEX clinical judgment items.